What is the main business of Ozein Bio-Technology Ltd.?

The main business activity of Ozein Bio-Technology Ltd. focuses on manufacture of perfumes and toilet preparations.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on July 18, 2016.

Where is the headquarters located?

The headquarters is located at: ul. Drukarska 2, 05-090 Jaworowa.

What is the share capital?

The share capital of the company is PLN 100,000 (approx. $27,012).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2022 to December 31, 2022.

What revenue was generated?

In 2022, the company generated total revenue of $201,411, representing a decrease of 37.8% compared to 2021.

Is the company profitable?

No, in 2022 the company was not profitable, reporting a net loss of $110,023.

What is the largest operating cost?

The largest operating cost category falls under external services. This category amounted to $43,811 in 2022, representing 25% of all operating expenses.

Ozein Bio-Technology Ltd.sp. z o.o.

Manufacture of perfumes and toilet preparations

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2016-07-18

Share capital

100,000.00 PLN

Registered address

ul. Drukarska 2, 05-090 Jaworowa, Poland

Website

ozein.com.pl

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 1 of 5 financial statements was filed late (for 2021, 77 days late).

2023not filed
202212/07/2023
202130/09/2022
202002/07/2021
201908/07/2020
201811/07/2019

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2022.

Industry · Manufacture of perfumes and toilet preparations270 / 572

Top 47%

Division · Manufacture of chemicals and chemical products1,136 / 1,945

Top 58%

Sector · Manufacturing22,011 / 33,759

Top 65%

Voivodeship · Mazowieckie63,326 / 142,058

Top 45%

Country · Poland229,822 / 495,976

Top 46%

Results vs industry

Revenue

This companyUSD 201.41kMedianUSD 178.92kAverageUSD 6.85m

Net profit

This companyUSD -110.02kMedianUSD 2.44kAverageUSD 466.40k

Operating costs

This companyUSD 178.65kMedianUSD 175.18kAverageUSD 6.10m

Assets

This companyUSD 1.67mMedianUSD 160.35kAverageUSD 5.64m

Industry

Authorized Representatives

Katarzyna Magdalena Sznelewskaage 54 – Attorney-in-fact (sole)

Siew Kheng Lean – Management Board Member

Shiliang Li – President of the Management Board

Manner of representation

Each member of the management board is authorised to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Siew Kheng Lean	150	$4,051.86	15%
Shiliang Li	550	$14,856.83	55%
Justyna Ewa Sadowska-Pietrzakage 47	150	$4,051.86	15%
Katarzyna Magdalena Sznelewskaage 54	150	$4,051.86	15%

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2016-08-16 to 2025-04-03.

Reason for removal: Art. 96 ust. 9 pkt 4 (taxpayer or their representative fails to appear on summons of tax authorities)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Trend Hairsp. z o.o. + limited partnership	$5,158,825.84	trendcosmetic.eu
FerrumlabsS.A.	$251,102.52	truemenskincare.com
SEE My Aurasp. z o.o.	$233,261.04	auradistribution.pl
IMU MedicalS.A.	$201,877.36	imumedical.com
Mycode Beautysp. z o.o.	$194,102.34	wwww.mycodebeauty.com
AJKsp. z o.o.	$30,188.87	parloy.com
Kabos Cosmeticssp. z o.o.	$25,287.53	kabos.pl
BY Corelsp. z o.o.	$22,392.81	bycorel.com
Nakoiosp. z o.o.	$5,999.46	nakoio.com
Admedicsp. z o.o.	$4,842.61	admedic.pl

Change history

Date	Event
2020-05-18	Address change (Ul. Henryka Sienkiewicza 115, 05-820, Piastów → Ul. Drukarska 2, 05-090, Jaworowa)
2016-07-18	Entered in the register

FAQ

Last updated: 2026-04-18